Promega Corporation

Determine Mechanism of Toxicity with Mitochondrial ToxGlo™ Assay

Cell Viablity Product Portfolio

Related Articles

Select an area of the image to view representative toxicity profiles

No Mitotoxicity Mitotoxicity With No Necrosis Mitotoxicity With Necrosis Primary Necrosis
Close

No Mitotoxicity

No Mitotoxicity

No changes in ATP or membrane integrity = No Mitotoxicity

K562 Cells (10,000/well) in 96-well plates were exposed to serial dilutions of test compound for 2 hours in glucose-free (galactose-supplemented) RPMI medium.

Close

Mitotoxicity With No Necrosis

Mitotoxicity - No Necrosis

Reduction in ATP with no necrosis = Mitochondrial toxicity

K562 Cells (10,000/well) in 96-well plates were exposed to serial dilutions of test compound for 2 hours in glucose-free (galactose-supplemented) RPMI medium.

Close

Mitotoxicity With Necrosis

Mitotoxicity - With Necrosis

Ablation of ATP leads to dose-dependent membrane integrity changes (necrosis) = Mitochondrial toxicity

K562 Cells (10,000/well) in 96-well plates were exposed to serial dilutions of test compound for 2 hours in glucose-free (galactose-supplemented) RPMI medium.

Close

Primary Necrosis

Primary Necrosis

Reduction in ATP with commensurate membrane integrity changes = Primary Necrosis

K562 Cells (10,000/well) in 96-well plates were exposed to serial dilutions of test compound for 2 hours in glucose-free (galactose-supplemented) RPMI medium.

Assay Overview

Single point assays of viability or cytotoxicity are not sufficient to determine mechanism of toxicity. The Mitochondrial ToxGlo™ Assay brings you the predictive data you need to distinguish mitochondrial dysfunction from other cytotoxic effects.

  • Predictive for mitochondrial toxicity
  • Results in under an hour
  • Easy automation
  • Simple detection with a standard plate reader

Assay Principle

The Mitochondrial ToxGlo™ Assay is based on the differential measurement of biomarkers associated with changes in cell membrane integrity and cellular ATP levels relative to vehicle-treated controls. The assay is performed in a single-well, with bioluminescent and fluorescent readouts.

  • Bioluminescent signal is proportional to ATP concentration
  • Fluorescent signal indicates loss of membrane integrity
  • The two sets of data are combined to produce profiles representative of mitochondrial dysfunction or other cytotoxic mechanisms.

Simple, "Add-Mix-Measure" Protocol

Simple add-mix-measure protocol is easy to implement and fast. No parallel processing in glucose-containing medium.

Promega

About Us

Connect With Us

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.